Furthermore, other studies revealed that 4β-hydroxycholesterol, a marker of PXR activity, is associated with factors that increase the risk of heart disease, such as obesity, hypertension, and impaired glucose metabolism [30], suggesting that PXR activation is a background factor in cardiac disorders. Here, NR1I2 is linked to hypertensive disorder.